NAFDAC warns of high-caffeine energy drink

Share Story

The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a public alert, No. 034/2023, regarding G Fuel brand Energy Drinks supplied by T&E Imports and GPAE Trading Corp. These products have been found to contain elevated levels of caffeine. NAFDAC Director-General, Prof. Mojisola Adeyeye, made this announcement in Abuja.

Adeyeye mentioned that the Netherlands Food and Consumer Product Safety Authority (NVWA) and the Canadian Food Inspection Agency (CFIA) have also recalled the product. She warned that high caffeine consumption can lead to adverse effects such as headaches, insomnia, irritability, and nervousness, especially in individuals sensitive to caffeine. Pregnant women are urged to avoid these products to reduce the risk of miscarriage and low birth weight.

See also  NAFDAC destroys fake, expired goods worth N16bn in Ogun

Adeyeye further highlighted that the affected products lack cautionary statements about daily consumption limits and are primarily sold online. NAFDAC does not have registration records for these products, and the agency advises consumers and retailers to cease using, selling, serving, or distributing them.

Your Website Title Advertisement Image Advertisement (apply here)
See also  NAFDAC investigates poisoning claims in plantain chips

Members of the public are encouraged to report any suspicious distribution or sale of unwholesome packaged food products to their nearest NAFDAC office. NAFDAC can be contacted at 0800-162-3322 or via email at sf.alert@nafdac.gov.ng.

Your Website Title Advertisement Image
See also  NAFDAC investigates poisoning claims in plantain chips

Healthcare professionals and patients are urged to report any adverse events or side effects associated with substandard NAFDAC-regulated products to their nearest NAFDAC office. Various reporting options are available, including the NAFDAC website (www.nafdac.gov.ng), the Med-safety application on Android and iOS stores, and email at pharmacovigilance@nafdac.gov.ng.

Share Article

Don't Miss